Amitiza (Lubiprostone)

Lubiprostone is a medicine used to help with certain digestive problems, like constipation. It works by helping the intestines move food along more quickly. It's usually taken as a liquid or a pill.

Brand names:Amitiza
Medication

What people taking Amitiza (Lubiprostone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Amitiza (Lubiprostone) for IBS (Irritable Bowel Syndrome)?

NameHow it went

About Amitiza (Lubiprostone)

What It's For

Lubiprostone, sold under the brand name Amitiza and as a generic, is a prescription capsule for long-lasting constipation. It is approved for three groups of adults: people with chronic idiopathic constipation, meaning ongoing hard, infrequent or difficult bowel movements with no identifiable cause; people whose constipation comes from taking opioid pain medicines for long-term pain not caused by active cancer; and women 18 and older with irritable bowel syndrome with constipation (IBS-C), a condition that combines recurring belly pain with constipation. It is usually considered after fiber, fluids and over-the-counter laxatives such as polyethylene glycol (MiraLAX) have not worked well enough, and it can be used instead of them or alongside them. It was not shown to help children and teenagers with constipation, and there is too little research in men to know how well it works for IBS-C in men.

How It Works

Stool moves more easily when the inside of the intestine is moist. Lubiprostone acts on the lining of the intestine, opening chloride channels (tiny gates in the cells) so that the lining releases more salt-rich fluid into the bowel. That extra fluid softens stool and helps the intestine move it along. The drug works locally in the gut and very little of it reaches the bloodstream. Opioids slow the bowel partly by reducing this natural fluid release, and lubiprostone can bypass that effect. Methadone, however, may blunt how well lubiprostone works.

Dosage & Administration

Lubiprostone comes as 8 microgram and 24 microgram capsules (microgram is often written mcg, a very small unit; older materials that say 24 milligrams are wrong). For chronic idiopathic constipation and opioid-induced constipation, the usual dose is 24 mcg twice a day. For IBS-C, it is 8 mcg twice a day. People with moderate or severe liver disease are started on a lower dose. Take each dose with food and water, which reduces nausea, and swallow the capsule whole without opening or chewing it. The prescriber and patient should check from time to time whether ongoing treatment is still needed.

Side Effects

Nausea is the most common side effect. In constipation trials at the full dose, close to 3 in 10 people had some nausea, compared with about 3 in 100 on placebo. Taking it with a meal usually helps, and nausea is less common at the lower IBS-C dose. Diarrhea, headache, belly pain, bloating and gas are also common. If diarrhea becomes severe, stop the medicine and contact the prescriber. Two less common reactions are worth knowing in advance. Some people feel chest tightness or have trouble taking a full breath within an hour of a dose; it usually fades within a few hours but can return with later doses, so tell the prescriber if it happens. Fainting or a sharp drop in blood pressure has also been reported, sometimes after the first dose and more often in people who also have diarrhea or vomiting or take blood pressure medicines. If you faint or feel close to fainting, stop lubiprostone and contact the prescriber. Rare reports include allergic reactions with rash, swelling or throat tightness, and ischemic colitis (reduced blood flow to part of the colon, which can cause sudden belly pain and bloody stools); these need prompt medical attention.

Interactions & Warnings

Lubiprostone must not be used if a bowel blockage (obstruction) is known or suspected, because pushing more fluid into a blocked intestine can make things worse. Anyone with symptoms that could suggest a blockage, such as severe belly pain, swelling of the abdomen or vomiting, should be checked before starting. It should also be avoided by people who already have severe diarrhea. Few drug interactions are known. For people taking methadone, a long-acting opioid used for pain or opioid use disorder, lubiprostone has not been shown to relieve opioid-related constipation. Medicines that lower blood pressure can add to the risk of fainting described above. There is too little information to know whether lubiprostone affects a pregnancy, so anyone pregnant or planning pregnancy should discuss it with the prescriber. During breastfeeding, watch the baby for diarrhea.

What to Expect

Lubiprostone often works quickly. In the main constipation trials, about 6 in 10 people had a bowel movement within a day of the first dose, compared with about a third on placebo, and people averaged roughly two more bowel movements a week than with placebo. Stools also tended to become softer, with less straining and bloating. Benefit is more modest for opioid-induced constipation and for IBS-C: in IBS-C trials, about 12 to 14 in 100 women reported clear overall relief over three months, compared with 6 to 8 in 100 on placebo. Lubiprostone treats symptoms rather than curing the underlying problem. When people stop taking it, bowel habits tend to drift back toward where they were within about a week, though they do not usually become worse than before. Many people use it for months or longer, with periodic check-ins about whether it is still helping and still needed.

Questions to Ask Your Doctor

  1. 1.Is lubiprostone a better next step for me than another over-the-counter or prescription constipation treatment?
  2. 2.What dose is right for my type of constipation, and does my liver health or anything else change it?
  3. 3.How long should I try it before we decide whether it is working?
  4. 4.Could any of my medicines, such as an opioid like methadone or a blood pressure medicine, affect how well or how safely it works?
  5. 5.What should I do if nausea, diarrhea or breathing discomfort shows up after a dose?

Last reviewed • Oct 2026

Educational content, not medical advice.